The activation of SDCCAG10, a cyclophilin associated with the spliceosome, is intricately linked to its role in RNA splicing within the cell nucleus. Compounds that modulate intracellular calcium levels or affect calcium-dependent phosphorylation processes exert an influence on the splicing machinery by altering the phosphorylation status of spliceosome-related proteins. This, in turn, can have a downstream effect on SDCCAG10, potentially enhancing its activity within the spliceosome complex. Additionally, inhibitors of serine/threonine phosphatases lead to the hyperphosphorylation of splicing factors, which is another route through which the functional activity of SDCCAG10 can be indirectly increased. Hyperphosphorylation of spliceosomal components can facilitate the assembly and function of the spliceosome, thereby augmenting the role of SDCCAG10 in RNA splicing events.
Another layer of regulatory influence involves histone acetylation and DNA methylation, which are pivotal in controlling gene expression levels of spliceosomal components. Chemicals that inhibit histone deacetylases or DNA methyltransferases can lead to the upregulation of genes encoding these components, subsequently supporting the capacity of SDCCAG10 to participate effectively within the spliceosome. Moreover, the stabilization of spliceosomal proteins via the inhibition of their degradation by proteasomes offers another indirect mechanism for enhancing SDCCAG10 activity. The presence of cAMP analogs that mimic the action of cAMP can also lead to increased phosphorylation within the spliceosome pathway, thereby indirectly promoting the functional activity of SDCCAG10.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
This compound binds to cyclophilins. SDCCAG10, being a cyclophilin, is engaged by cyclosporine A, leading to an increase in its peptidyl-prolyl isomerase activity which is essential for proper splicing events. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Binds to FKBP family proteins, which are part of the cyclophilin family, to which SDCCAG10 belongs. Binding of FK-506 to SDCCAG10 can enhance its conformational regulation capabilities within the spliceosome complex. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This macrolide compound binds to FKBP proteins and could interact with SDCCAG10 to modulate its role in mRNA splicing by stabilizing protein-protein interactions within the spliceosome. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
A CDK4/6 inhibitor that, by hindering cell cycle progression, may indirectly enhance the expression and functional activity of SDCCAG10 during the G1 phase of the cell cycle where mRNA splicing is critical. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid that influences multiple signaling pathways including those related to cell cycle and apoptosis, which may indirectly necessitate the activation of SDCCAG10 for mRNA processing during stress responses. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By modulating sirtuin activity which is implicated in chromatin remodeling, resveratrol may indirectly necessitate the enhanced activity of SDCCAG10 in the splicing of mRNAs related to longevity and stress response. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
This compound has multiple cellular targets and by affecting transcriptional regulation, may indirectly increase the demand for SDCCAG10's role in mRNA splicing and maturation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC inhibitor that could lead to an upregulated expression of genes, possibly including those that require SDCCAG10's involvement in splicing for their mature mRNA production. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can increase acetylation of histones, potentially enhancing the transcription of genes that involve SDCCAG10 in their mRNA splicing and processing. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
As an HDAC inhibitor, it may create a scenario where there is an elevated level of gene transcription, requiring the increased activity of SDCCAG10 for the splicing of newly transcribed mRNAs. | ||||||